The FDA has approved a new indication for Ortho-McNeil's Levaquin Tablets/Injection (levofloxacin tablets/injection), to treat complicated skin and skin structure infections at a dose of 750 mg once daily.
This is the ninth indication for Levaquin, which is already widely used in 500 mg and 250 mg doses to treat respiratory, urinary and other types of skin infections. Complicated skin and skin structure infections include deep wounds--surgical incisions, bites and lacerations that have become infected, major abscesses and infected ulcers. While often resulting from surgery, complicated skin infections are also common in patients with compromised immune response to infection, such as the elderly and individuals with HIV/AIDS.
COPYRIGHT 2000 Lebhar-Friedman, Inc.
COPYRIGHT 2000 Gale Group